Results 211 to 220 of about 69,085 (277)

Activating NRAS Mutation [PDF]

, 2020
openaire   +1 more source

Malignant Melanoma: Landscape of Molecular Markers. [PDF]

Biomedicines
Winter M, Ebner S, Baum V, Kiil K, Rauschendorf MA, Wild PJ.   +5 more
europepmc   +1 more source

NRAS NP_002515.1:p.G12S [PDF]

, 2020
openaire   +1 more source

Non-Invasive Follicular Cell-Derived Thyroid Neoplasm Composed Entirely of Spindle Cells Harboring NRAS p.Q61R Mutation and Variable Atypia. [PDF]

Endocr Pathol
Odate T, Shimekake S, Horiuchi T, Sakurai D, Kondo T.   +4 more
europepmc   +1 more source

NRAS NP_002515.1:p.Q61K [PDF]

, 2020
openaire   +1 more source

Activity of direct KRAS(G12C) inhibitors in preclinical models of pediatric cancer. [PDF]

Mol Cancer Ther
Price HE, Stauffer S, Lee H, Isanogle KA, Wu Y, Powell K, Baker A, Stauffer L, Perciaccante AJ, Jewell CP, Hernandez ER, Aljabri AK, Odeniyide P, Pratilas CA, Burgan W, Edmondson EF, Difilippantonio S, Kortum RL, Shern JF, Jenkins LM, Rossman KL, Yohe ME.   +21 more
europepmc   +1 more source

NRAS NP_002515.1:p.G13X [PDF]

, 2020
openaire   +1 more source

Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy. [PDF]

Blood Adv
Wei AH, Panayiotidis P, Montesinos P, Laribi K, Ivanov V, Kim I, Novak J, Champion R, Fiedler W, Pagoni M, Bergeron J, Ting SB, Hou JZ, Yamauchi T, Wang J, Strickland SA, Savona MR, Lin TL, Enjeti A, Tiong IS, Lee S, Roboz GJ, Popovic R, Jiang Q, Liu Z, Sun Y, Mendes W, Chyla B, DiNardo CD.   +28 more
europepmc   +1 more source

Key institutional issues and possible scenarios for the review of the EC electronic communications framework [PDF]

Larouche, P., Visser, M.C.B.F. de
core   +1 more source

RAS(ON) Multiselective Inhibition Drives Antitumor Immunity in Preclinical Models of NRAS-Mutant Melanoma. [PDF]

Cancer Immunol Res
Anastacio Da Costa Carvalho L, Tovbis Shifrin N, Phadke MS, Emmons MF, Pechuan-Jorge X, Mbuga F, Ospina OE, Chow C, Seu L, Rose OL, Hegde A, Khushalani NI, Quintana E, Smalley KSM.   +13 more
europepmc   +1 more source